Elpiscience Biopharmaceuticals
Shanghai
About Elpiscience Biopharmaceuticals
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies. The company has a robust pipeline of globally innovative molecules, covering wide range of targets in immuno-oncology. Founded and managed by a team of biopharma industry leaders and scientists, Elpiscience endeavors to advance at least one innovative molecule into the clinic each year to benefit cancer patients worldwide.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $260.0M
- Funding stage: Late Stage Venture
- Last round: Series C (May 2021)
- Website: elpiscience.com
- Phone: +86 21 50651310
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/elpiscience-biopharmaceuticals-88679 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.